Author

David L. Healy

Observed names: D L Healy, D. HEALY, D. Healy, D. L. HEALY, D. L. Healy, D.L Healy, D.L. HEALY, D.L. Healy, DL Healy, David L Healy

Institution: Monash Medical Centre

Observed institutions: The University of Sydney, National Institutes of Health, Royal Women's Hospital, The University of Melbourne, Epworth Hospital, Cardiff Royal Infirmary, Monash Medical Centre, Monash Health, Monash IVF, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Health and Medical Research Council, Monash University, Wellcome Trust, Medical Research Council, University of Edinburgh

OpenAlex ID: A5110069090

Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome

1994 · N McClure, D.L Healy, et al. · The Lancet · 372

Uterine fibroids: A clinical review

1990 · B. J. VOLLENHOVEN, A. S. LAWRENCE, et al. · BJOG An International Journal of Obstetrics & Gynaecology · 357

Circulating Immunoreactive Inhibin Levels During the Normal Human Menstrual Cycle*

1987 · R. I. McLACHLAN, D. M. ROBERTSON, et al. · The Journal of Clinical Endocrinology & Metabolism · 297

Prevalence and risk factors for obstetric haemorrhage in 6730 singleton births after assisted reproductive technology in Victoria Australia

2009 · D.L. Healy, S. Breheny, et al. · Human Reproduction · 240

PDF

Factors affecting low birthweight after assisted reproduction technology: difference between transfer of fresh and cryopreserved embryos suggests an adverse effect of oocyte collection

2008 · W. Shih, D.D. Rushford, et al. · Human Reproduction · 210

Increased risk of blastogenesis birth defects, arising in the first 4 weeks of pregnancy, after assisted reproductive technologies

2009 · J. L. Halliday, O. C. Ukoumunne, et al. · Human Reproduction · 193

Pregnancies conceived using assisted reproductive technologies (ART) have low levels of pregnancy-associated plasma protein-A (PAPP-A) leading to a high rate of false-positive results in first trimester screening for Down syndrome

2009 · D.J. Amor, J.X. Xu, et al. · Human Reproduction · 178

Angiongenesis: a new theory for endometriosis

1998 · D. Healy · Human Reproduction Update · 173

The human placenta: A novel source of inhibin

1986 · R.I. McLachlan, D.L. Healy, et al. · Biochemical and Biophysical Research Communications · 119

The Stimulation of Prostaglandin Production by Two Antiprogesterone Steroids in Human Endometrial Cells

1986 · R. W. KELLY, D. L. HEALY, et al. · The Journal of Clinical Endocrinology & Metabolism · 93

Pituitary and Adrenal Responses to the Anti-progesterone and Anti-glucocorticoid Steroid Ru 486 in Primates1

1983 · D.L. HEALY, G.P. CHROUSOS, et al. · The Journal of Clinical Endocrinology & Metabolism · 81

Relationship between Serum Inhibin A and B and Ovarian Follicle Development after a Daily Fixed Dose Administration of Recombinant Follicle-Stimulating Hormone1

2000 · T. Eldar-Geva, D. M. Robertson, et al. · The Journal of Clinical Endocrinology & Metabolism · 66

Characterization of inhibin immunoreactivity in post‐menopausal women with ovarian tumours

1996 · H. G. Burger, D. M. Robertson, et al. · Clinical Endocrinology · 62

The Maternal Ovary Is Not the Source of Circulating Inhibin Levels During Human Pregnancy

1987 · R. I. McLACHLAN, D. L. HEALY, et al. · Clinical Endocrinology · 62

Inhibins/activins as diagnostic markers for ovarian cancer

2002 · D.M. Robertson, T. Stephenson, et al. · Molecular and Cellular Endocrinology · 59

Smooth muscle alpha actin and myosin heavy chain expression in the vascular smooth muscle cells surrounding human endometrial arterioles

1999 · K.M. Abberton, D.L. Healy, et al. · Human Reproduction · 56

Circulating Immunoreactive Oxytocin During the Human Menstrual Cycle Comes From the Pituitary and Is Estradiol Dependent*

1989 · L. SHUKOVSKI, D. L. HEALY, et al. · The Journal of Clinical Endocrinology & Metabolism · 56

Endothelial cell proliferation in the endometrium of women with menorrhagia and in women following endometrial ablation

1996 · J. Kooy, N.H. Taylor, et al. · Human Reproduction · 51

Cumulative pregnancy rates in couples with anovulatory infertility compared with unexplained infertility in an ovulation induction programme

1997 · N. Tadokoro, B. Vollenhoven, et al. · Human Reproduction · 50

Shrinkage of a uterine fibroid after subcutaneous infusion of a LHRH agonist.

1984 · D L Healy, H M Fraser, et al. · BMJ · 46

PDF

Steroid receptor binding and messenger RNA expression in fibroids from untreated and gonadotrophin‐releasing hormone agonist pretreated women

1994 · B. J. Vollenhoven, P. Pearce, et al. · Clinical Endocrinology · 44

Impact of Uterine Fibroids on ART Outcome

2000 · David L Healy · Environmental Health Perspectives · 43

Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses

2020 · Eun Young Kang, Dane Cheasley, et al. · Modern Pathology · 42

PDF

Ovine trophoblast protein-1 and human interferon alpha reduce prostaglandin synthesis by ovine endometrial cells

1989 · L.A. Salamonsen, J. Manikhot, et al. · Prostaglandins · 41

Inhibin and ovarian cancer

1998 · H.G Burger, A Baillie, et al. · Journal of Reproductive Immunology · 38

Works count: 75

Citation count: 3,730

H-index: 30

I10-index: 52